Sin categoría Auro Pharma receives Health Canada Approval for generic version of XIGDUO® (Auro-Dapagliflozin/Metformin 5mg/850mg and 5mg/1000mg Tablets) auropharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated…Auropharma04/01/2022
Sin categoría Auro Pharma receives Health Canada Approval for generic version of JANUVIA® (Auro-Sitagliptin 25mg, 50mg & 100mg Tablets) auropharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated…Auropharma04/15/2022
Sin categoría Auro Pharma receives Health Canada Approval for generic version of FORXIGA® (Auro-Dapagliflozin 5mg & 10mg Tablets) Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam ex ligula, ullamcorper vitae massa ac,…Auropharma05/01/2022
Sin categoría Auro Pharma receives Health Canada Approval for generic version of XELJIANZ® (Auro-Tofacitinib 5mg & 10mg Tablets) auropharma Limited, has received final approval from U.S. Food and Drug | Administration for its…Auropharma05/15/2022
Sin categoría Auro Pharma Receives Health Canada Approval for generic version of ULORIC® (AURO-Febuxostat 80mg tablets) auropharma Limited, has received final approval from U.S. Food and Drug | Administration for its…Auropharma07/07/2022
Sin categoría Auro Pharma receives Health Canada Approval for generic version of OTEZLA® (Auro-Apremilast 30mg Tablets) auropharma Limited, has received final approval from U.S. Food and Drug | Administration for its…Auropharma07/07/2022